These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Molecular therapy of muscular dystrophy]. Takeda S Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475 [TBL] [Abstract][Full Text] [Related]
6. [Current state and prospects for gene therapy of Duchenne muscular dystrophy in the world and in Russia]. Baranov VS; Baranov AN; Zelenin AV Genetika; 2001 Aug; 37(8):1046-54. PubMed ID: 11642103 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy for Duchenne dystrophy. Engel AG Ann Neurol; 1993 Jul; 34(1):3-4. PubMed ID: 8517677 [No Abstract] [Full Text] [Related]
8. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy. Stedman HH Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558 [TBL] [Abstract][Full Text] [Related]
9. The principles of gene therapy in Duchenne muscular dystrophy. Karpati G; Acsadi G Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies. Mendell JR Adv Exp Med Biol; 1990; 280():287-95. PubMed ID: 2248150 [No Abstract] [Full Text] [Related]
11. Gene therapy for muscular dystrophy: current progress and future prospects. Trollet C; Athanasopoulos T; Popplewell L; Malerba A; Dickson G Expert Opin Biol Ther; 2009 Jul; 9(7):849-66. PubMed ID: 19527108 [TBL] [Abstract][Full Text] [Related]
12. [For the present Duchenne' disease should not be treated with prednisone]. Jennekens FG; de Visser M; Wintzen AR; Wokke JH Ned Tijdschr Geneeskd; 1996 May; 140(21):1109-11. PubMed ID: 8692335 [No Abstract] [Full Text] [Related]
13. [The genetic basis of muscle disease]. Bindoff L; Gilhus NE Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2588-92. PubMed ID: 14714051 [TBL] [Abstract][Full Text] [Related]